Genetic and bioinformatic analysis of RHO and PRPH2 variants in north Indian retinitis pigmentosa patients
- PMID: 40880019
- DOI: 10.1007/s10384-025-01262-8
Genetic and bioinformatic analysis of RHO and PRPH2 variants in north Indian retinitis pigmentosa patients
Abstract
Purpose: Retinitis Pigmentosa (RP) represents the most common form of inherited retinal dystrophy (IRD), identified by a gradual degeneration of photoreceptors, ultimately resulting in nyctalopia and impaired vision. This study was conducted to screen the rhodopsin and peripherin2 genes for possible pathogenic mutations in north Indian RP patients.
Study design: We focused on assessing the whole coding region and the intron-exon boundaries of RHO and PRPH2 genes in RP patients and control subjects.
Methods: After institutional human ethical clearance and informed consent, a total of seventy-five sporadic cases of RP and one hundred control subjects were enrolled in the current study. Genomic DNA was extracted from the peripheral blood samples of patients and control subjects. PCR-DNA sequencing was performed for coding exons and intron-exon boundaries of RHO and PRPH2 genes to identify nucleotide variations in patients and controls. The pathogenicity of identified missense variants was predicted by using six different bioinformatics tools. Structural changes of the protein were analyzed using Garnier-Osguthorpe-Robson, PyMol, ChimeraX, and Molecular Dynamic simulations.
Results: A total of twenty sequence variants which include 7 missense, 3 synonymous and 10 intronic changes in RHO gene, and fourteen sequence variants which include 9 missense, 4 synonymous and 1 intronic variant in PRPH2 gene were identified. Bioinformatic analysis revealed two possible pathogenic missense mutations [p.(E150K) and p.(P347L)] in RHO gene and three possible pathogenic mutations [p.(G31D), p.(D84N), and p.(R220Q)] in PRPH2 gene. All five mutations have been previously reported and are documented in publicly available variant databases. Structural alterations were observed in the secondary and tertiary structures of the mutated proteins in cases of pathogenic changes both in rhodopsin and peripherin2 proteins. These structural changes led to protein dysfunction, contributing to disease progression.
Conclusion: In our study population, we identified five previously reported potentially pathogenic missense variants in the RHO and PRPH2 genes, which are associated with retinitis pigmentosa. This data will add to the existing repertoire of disease-causing mutations.
Keywords: Mutation Taster; Peripherin2; Photoreceptors; Retinitis pigmentosa; Rhodopsin.
© 2025. Japanese Ophthalmological Society.
Conflict of interest statement
Declarations. Conflict of interest: A. Bhardwaj, None; J. Phogat, None; M. Yadav, None; A. Yadav, None; V. Panghal, None; M. Singh, None; S. Sharma, None; R. Kumar, None; M. Tanwar, None.
Similar articles
-
Paucity of optineurin gene variants in Indian juvenile open-angle glaucoma patients.Indian J Ophthalmol. 2025 Aug 1;73(8):1181-1189. doi: 10.4103/IJO.IJO_1512_24. Epub 2025 Jul 28. Indian J Ophthalmol. 2025. PMID: 40719721
-
Vitamin A and fish oils for retinitis pigmentosa.Cochrane Database Syst Rev. 2013 Dec 19;2013(12):CD008428. doi: 10.1002/14651858.CD008428.pub2. Cochrane Database Syst Rev. 2013. Update in: Cochrane Database Syst Rev. 2020 Jun 18;6(6):CD008428. doi: 10.1002/14651858.CD008428.pub3. PMID: 24357340 Free PMC article. Updated.
-
Identification of IDH3G, encoding the gamma subunit of mitochondrial isocitrate dehydrogenase, as a novel candidate gene for X-linked retinitis pigmentosa.Genet Med. 2025 Jun;27(6):101418. doi: 10.1016/j.gim.2025.101418. Epub 2025 Mar 19. Genet Med. 2025. PMID: 40119724
-
The role of SIX6 gene in juvenile open-angle glaucoma: a subtle contributor to the mutational landscape.Jpn J Ophthalmol. 2025 Jun 27. doi: 10.1007/s10384-025-01233-z. Online ahead of print. Jpn J Ophthalmol. 2025. PMID: 40576883
-
Prevalence Estimates and Genetic Diversity for Autosomal Dominant Retinitis Pigmentosa Due to RHO, c.68C>A (p.P23H) Variant.Am J Ophthalmol. 2024 Dec;268:340-347. doi: 10.1016/j.ajo.2024.08.038. Epub 2024 Sep 14. Am J Ophthalmol. 2024. PMID: 39278389
References
-
- Kamde SP, Anjankar A. Retinitis pigmentosa: pathogenesis, diagnostic findings, and treatment. Cureus. 2023;15(10):e48006. https://doi.org/10.7759/cureus.48006 . - PubMed - PMC
-
- Vingolo EM, Mascolo S, Miccichè F, Manco G. Retinitis pigmentosa: from pathomolecular mechanisms to therapeutic strategies. Medicina (Mex). 2024;60:189.
-
- Song D-J, Bao X-L, Fan B, Li G-Y. Mechanism of cone degeneration in retinitis igmentosa. Cell Mol Neurobiol. 2023;43:1037–48. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources